Stoneridge Investment Partners’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-751
Closed -$14K 107
2022
Q1
$14K Hold
751
0.01% 99
2021
Q4
$13K Hold
751
0.01% 110
2021
Q3
$28K Hold
751
0.01% 109
2021
Q2
$45K Hold
751
0.02% 102
2021
Q1
$50K Hold
751
0.03% 103
2020
Q4
$45K Hold
751
0.03% 103
2020
Q3
$59K Buy
751
+245
+48% +$19.2K 0.04% 105
2020
Q2
$32K Hold
506
0.01% 111
2020
Q1
$27K Hold
506
0.01% 113
2019
Q4
$61K Hold
506
0.02% 129
2019
Q3
$92K Hold
506
0.03% 124
2019
Q2
$66K Hold
506
0.02% 111
2019
Q1
$123K Hold
506
0.04% 111
2018
Q4
$96K Hold
506
0.03% 119
2018
Q3
$166K Hold
506
0.04% 123
2018
Q2
$158K Sell
506
-1,661
-77% -$519K 0.03% 111
2018
Q1
$528K Sell
2,167
-747
-26% -$182K 0.09% 110
2017
Q4
$880K Hold
2,914
0.14% 98
2017
Q3
$771K Sell
2,914
-1,001
-26% -$265K 0.12% 112
2017
Q2
$1.03M Sell
3,915
-5,434
-58% -$1.43M 0.15% 114
2017
Q1
$3.37M Sell
9,349
-953
-9% -$343K 0.45% 83
2016
Q4
$2.97M Buy
10,302
+1,166
+13% +$336K 0.4% 89
2016
Q3
$3.11M Sell
9,136
-202
-2% -$68.8K 0.45% 84
2016
Q2
$3.97M Sell
9,338
-42
-0.4% -$17.9K 0.59% 50
2016
Q1
$3M Sell
9,380
-524
-5% -$168K 0.44% 79
2015
Q4
$5.14M Sell
9,904
-293
-3% -$152K 0.69% 48
2015
Q3
$2.99M Buy
10,197
+2,506
+33% +$734K 0.42% 67
2015
Q2
$3.02M Sell
7,691
-3,230
-30% -$1.27M 0.37% 78
2015
Q1
$3.3M Buy
10,921
+80
+0.7% +$24.2K 0.39% 84
2014
Q4
$2.41M Buy
10,841
+1,777
+20% +$395K 0.32% 107
2014
Q3
$2.1M Buy
9,064
+610
+7% +$142K 0.31% 109
2014
Q2
$1.87M Buy
+8,454
New +$1.87M 0.28% 119
2014
Q1
Sell
-2,704
Closed -$704K 229
2013
Q4
$704K Buy
+2,704
New +$704K 0.14% 103